• Return to Headlines

Shares of Becton Dickinson Rise Above Previous 52-Week High

By James Quinn

Becton Dickinson (NYSE:BDX) traded at a new 52-week high today of $200.92. This new high was reached on below average trading volume as 99,000 shares traded hands, while the average 30-day volume is approximately 885,000 shares.

Becton Dickinson has overhead space with shares priced $200.77, or 0.3% below the average consensus analyst price target of $201.31. The stock should find initial support at its 50-day moving average (MA) of $153.96 and further support at its 200-day MA of $147.03.

Becton Dickinson share prices have moved between a 52-week high of $200.92 and a 52-week low of $161.29 and are now trading 24% above that low price at $200.77 per share. Over the last five market days, the 200-day moving average (MA) has gone up 0.2% while the 50-day MA has advanced 0.8%.

Becton, Dickinson and Company is a global medical technology company engaged principally in the development, manufacture, and sale of medical devices, instrument systems, and reagents used by healthcare institutions, life science researchers, clinical laboratories, the pharmaceutical industry, and the general public.

SmarTrend recommended that subscribers consider buying shares of Becton Dickinson on January 10th, 2017 as our proprietary SmarTrend analytics indicated a new Uptrend was in progress when shares hit $170.63. Since that recommendation, shares of Becton Dickinson have risen 17.6%. We continue to monitor BDX for any potential shift so investors can protect gains and will alert SmarTrend subscribers immediately.

Keywords: 52 week high/lows becton dickinson

Ticker(s): BDX